Bartholin gland transitional cell carcinoma

MONDO:0002828

A rare carcinoma that arises from the Bartholin gland and is characterized by the presence of malignant urothelial-type epithelial cells.

Also known as: Bartholin gland transitional cell carcinoma, Bartholin's gland transitional cell carcinoma, major vestibular gland transitional cell carcinoma

2837 clinical trials for this condition and its sub-types, 1 tagged with Bartholin gland transitional cell carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Transitional cell carcinoma (721) ↑ Bartholin gland carcinoma (1)

Including sub-types (2837) Tagged with Bartholin gland transitional cell carcinoma (1)

Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Bartholin gland transitional cell carcinoma

Where it sits in the disease tree

Immunotherapy duo takes on rare tumors